- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1798EUR$2,000USD£1,542GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1349EUR$1,500USD£1,156GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1349EUR$1,500USD£1,156GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1349EUR$1,500USD£1,156GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1349EUR$1,500USD£1,156GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1349EUR$1,500USD£1,156GBP
- Clinical Trials
- April 2025
- 70 Pages
Global
From €1349EUR$1,500USD£1,156GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1124EUR$1,250USD£963GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1124EUR$1,250USD£963GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1124EUR$1,250USD£963GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1124EUR$1,250USD£963GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1124EUR$1,250USD£963GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1124EUR$1,250USD£963GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1124EUR$1,250USD£963GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1124EUR$1,250USD£963GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1124EUR$1,250USD£963GBP
- Report
- December 2024
- 30 Pages
Global
From €2922EUR$3,250USD£2,505GBP
- Report
- August 2024
- 150 Pages
Global
From €3372EUR$3,750USD£2,890GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3372EUR$3,750USD£2,890GBP
- Report
- July 2024
- 150 Pages
Global
From €3372EUR$3,750USD£2,890GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more